Lantern Pharma Inc. Common Stock (LTRN) News
Latest headlines that mention LTRN, newest first · each headline opens the original publisher
- Last price
- $0.62
- Day change
- -1.83%
- Next earnings
- 2026-11-11
LTRN headlines
latest coverageLP-300 shows strong efficacy in lung cancer while operating losses shrink 25%.
Image source: The Motley Fool. Thursday, March 27, 2025 at 4:30 p.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading
LTRN news alerts
Get an alert by email or push when a new headline mentions LTRN.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.